Supervisory Board Proposes New Statutory Auditor
- Election of Deloitte GmbH Wirtschaftsprüfungsgesellschaft recommended to the Annual General Meeting
- Statutory auditor rotation planned as of fiscal 2023
At its meeting on July 30, 2021, the Supervisory Board of Merck KGaA, Darmstadt, Germany, resolved to propose Deloitte GmbH Wirtschaftsprüfungsgesellschaft, Munich, Germany, to the Annual General Meeting as statutory auditor for the annual financial statements and consolidated financial statements of Merck KGaA, Darmstadt, Germany, for fiscal 2023. The resolution was made on the basis of the recommendation by the Audit Committee.
This decision was preceded by a public and non-discriminatory tender process in accordance with the legal requirements for the selection of a new auditor as of fiscal 2023 for Merck KGaA, Darmstadt, Germany, and the Group under the supervision of the Supervisory Board and the Audit Committee. In order to implement the provisions of Regulation (EU) No. 537/2014 on the mandatory rotation of the auditor, such an invitation to tender would have had to be issued for the first time for fiscal 2024.
Since 1995, KPMG AG Wirtschaftsprüfungsgesellschaft, Berlin, Germany, has been the audit firm for the statutory audit of the annual financial statements and consolidated financial statements of Merck KGaA, Darmstadt, Germany.
All Merck KGaA, Darmstadt, Germany, press releases are distributed by e-mail at the same time they become available on the EMD Group Website. In case you are a resident of the USA or Canada please go to www.emdgroup.com/subscribe to register for your online subscription of this service as our geo-targeting requires new links in the email. You may later change your selection or discontinue this service.
About Merck KGaA, Darmstadt, Germany
Merck KGaA, Darmstadt, Germany, a leading science and technology company, operates across healthcare, life science and electronics. Around 58,000 employees work to make a positive difference to millions of people’s lives every day by creating more joyful and sustainable ways to live. From advancing gene editing technologies and discovering unique ways to treat the most challenging diseases to enabling the intelligence of devices – the company is everywhere. In 2020, Merck KGaA, Darmstadt, Germany, generated sales of € 17.5 billion in 66 countries.
The company holds the global rights to the name and trademark “Merck” internationally. The only exceptions are the United States and Canada, where the business sectors of Merck KGaA, Darmstadt, Germany operate as EMD Serono in healthcare, MilliporeSigma in life science, and EMD Electronics. Since its founding in 1668, scientific exploration and responsible entrepreneurship have been key to the company’s technological and scientific advances. To this day, the founding family remains the majority owner of the publicly listed company.
MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, has doubled its high-potent active pharmaceutical ingredients (HPAPI) production capacity with the expansion of ...